5-(3-chlorobenzyl)-1,2-dihydro-2-thioxo-4(3H)-pyrimidinone | 63204-32-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 5-(3-chlorobenzyl)-1,2-dihydro-2-thioxo-4(3H)-pyrimidinone
• 英文别名: 5-(3-chloro-benzyl)-2-thioxo-2,3-dihydro-1H-pyrimidin-4-one；5-(3-chlorobenzyl)-2-thiouracil；5-(3-Chlorbenzyl)-2-thiouracil；5-[(3-chlorophenyl)methyl]-2-sulfanylidene-1H-pyrimidin-4-one
• CAS: 63204-32-0
• 化学式: C₁₁H₉ClN₂OS
• 分子量: 252.724
• InChiKey: UQOLDXDLRIVWNO-UHFFFAOYSA-N

物化性质

• 密度：
  1.43±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  73.2
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  5-(3-chlorobenzyl)-1,2-dihydro-2-thioxo-4(3H)-pyrimidinone 在 溶剂黄146 、 牛血清白蛋白 、 氯乙酸 作用下， 反应 36.58h， 生成 2-[[5-[(3-Chlorophenyl)methyl]-2,4-dioxopyrimidin-1-yl]methoxy]ethyl acetate
  参考文献：
  名称：

  Inhibition of uridine phosphorylase: synthesis and structure-activity relationships of aryl-substituted 5-benzyluracils and 1-[(2-hydroxyethoxy)methyl]-5-benzyluracils.

  摘要：

  A series of 1-[(2-hydroxyethoxy)methyl]-5-benzyluracils were synthesized and tested for inhibition of murine liver uridine phosphorylase (UrdPase). Inhibitors of UrdPase are reported to enhance the chemotherapeutic utility of 5-fluoro-2'-deoxyuridine and 5-fluorouracil and to ameliorate zidovudine-induced anemia in animal models. We prepared a series of 5-aryl-substituted analogues of 5-benzylacyclouridine (BAU), a good inhibitor of UrdPase (IC50 of 0.46 mu M), to develop a compound with enhanced potency and improved pharmacokinetics. The first phase of structure-activity relationship studies on a series of 32 aryl-substituted 5-benzyluracils found several 5-(3-alkoxybenzyl) analogues of 5-benzyluracil with enhanced potency. The acyclovir side chain, the (2-hydroxyethoxy)methyl group, was substituted on the more potent aryl-substituted 5-benzyluracils. The two most potent compounds, 10y (3-propoxy) and 10dd (3-sec-butoxy), were inhibitors of UrdPase with IC(50)s of 0.047 and 0.027 mu M, respectively. Six compounds were tested in vivo for effects on steady-state concentrations of circulating uridine in rats. Plasma uridine levels were elevated 3-9-fold by compound levels that ranged from 8 to 50 mu M.

  DOI：

  10.1021/jm00019a015
• 作为产物：
  描述：

  乙基3-(3-氯苯基)丙酸酯 在 sodium 作用下， 以 乙醚 、 乙醇 为溶剂， 反应 25.0h， 生成 5-(3-chlorobenzyl)-1,2-dihydro-2-thioxo-4(3H)-pyrimidinone
  参考文献：
  名称：

  Isocytosine H2-receptor histamine antagonists I. Oxmetidine and related compounds

  摘要：

  DOI：

  10.1016/0223-5234(88)90167-5

文献信息

• 4-Pyrimidone compounds
  申请人：Smith Kline & French Laboratories Limited

  公开号：US04145546A1

  公开（公告）日：1979-03-20

  The compounds are substituted isocytosines which are histamine H.sub.2 -antagonists. Two specific compounds of the present invention are 2-\x9b2-(5-methyl-4-imidazolylmethylthio)-ethylamino!-5-(3-methoxybenzyl)-4-p\n' yrimidone and 2-\x9b2-(5-methyl-4-imidazolylmethylthio)ethylamino!-5-benzyloxy-4-pyrimidone\n' .

  这些化合物是取代的异胞嘧啶，是组胺H.sub.2-拮抗剂。本发明的两种特定化合物是2-β2-(5-甲基-4-咪唑基甲硫基)-乙基氨基-5-(3-甲氧基苄基)-4-吡咯啉酮和2-β2-(5-甲基-4-咪唑基甲硫基)乙基氨基-5-苄氧基-4-吡咯啉酮。
• BROWN, T. H.;DURANT, G. J.;EMMETT, J. C.;GANELLIN, C. R.
  作者：BROWN, T. H.、DURANT, G. J.、EMMETT, J. C.、GANELLIN, C. R.

  DOI：——

  日期：——
• US4145546A
  申请人：——

  公开号：US4145546A

  公开（公告）日：1979-03-20
• US4159329A
  申请人：——

  公开号：US4159329A

  公开（公告）日：1979-06-26
• US4218452A
  申请人：——

  公开号：US4218452A

  公开（公告）日：1980-08-19